Showing results (81-90 of 198) with videos related to

Sort By:
Pageof 20
Journal of the Endocrine Society|February 8, 2024
Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat BonesLilly Velentza, Malin Wickström, Per Kogner, et al.
Cell Research|February 13, 2008
Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cellsLena-Maria Carlson, Sven Påhlman, Anna De Geer, et al.
Pigment Cell Research|July 15, 2004
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cellsBertil Kågedal, Anita Kullman, Liselotte Lenner, et al.
Scientific Reports|May 17, 2023
Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growthLilly Velentza, Malin Wickström, Per Kogner, et al.
Clinical Chemistry|January 1, 2003
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastoma cells in blood and bone marrowCatarina Träger, Per Kogner, Magnus Lindskog, et al.
Pediatrics|July 30, 2024
Bone Mineral Density in Survivors of Childhood Cancer: A Meta-AnalysisLilly Velentza, Panagiotis Filis, Mari Wilhelmsson, et al.
Cancer Letters|November 18, 2018
RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanismAni Azatyan, Gabriel Gallo-Oller, Yumei Diao, et al.
International Journal of Oncology|November 18, 2004
Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAILJohn I Johnsen, Ingvild Pettersen, Frida Ponthan, et al.
Pageof 20